pe
pep-05254 v1 CC-BY-SA-4.0

Aureocin A53 anticancer peptide

A lab-made peptide being studied for its ability to kill cancer cells; experimental, not an approved drug.

statusbioassayed targetANTICANCER length53 aa refs1
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.912
avg pLDDT95.9
ranking score0.950
STRUCTURE · PEP-05254 × ANTICANCER
ranking0.950
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence53 aa
1510152025303540455053
MAGFLKVVQILAKYGSKA VQWAWANKGKILDWINAG QAIDWVVEKIKQILGIK
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.9497117400169373 boltz-2
3-letter notation
Met-Ala-Gly-Phe-Leu-Lys-Val-Val-Gln-Ile-Leu-Ala-Lys-Tyr-Gly-Ser-Lys-Ala-Val-Gln-Trp-Ala-Trp-Ala-Asn-Lys-Gly-Lys-Ile-Leu-Asp-Trp-Ile-Asn-Ala-Gly-Gln-Ala-Ile-Asp-Trp-Val-Val-Glu-Lys-Ile-Lys-Gln-Ile-Leu-Gly-Ile-Lys
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). Aureocin A53 anticancer peptide (pep-05254, v1). PeptideModel. https://peptidemodel.com/card/pep-05254
@peptide{pep05254,
  sequence = {MAGFLKVVQILAKYGSKAVQWAWANKGKILDWINAGQAIDWVVEKIKQILGIK},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 1 by signal overlap
references 1 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use